Sign in
4

Changes in Ownership

Marker Therapeutics, Inc. Filed Acc 0001209191-22-032175

Options or other derivatives

  • Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Laskow-Pooley David · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…